These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24800213)

  • 1. Oleoylethanolamide: a novel potential pharmacological alternative to cannabinoid antagonists for the control of appetite.
    Romano A; Coccurello R; Giacovazzo G; Bedse G; Moles A; Gaetani S
    Biomed Res Int; 2014; 2014():203425. PubMed ID: 24800213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.
    Gómez R; Navarro M; Ferrer B; Trigo JM; Bilbao A; Del Arco I; Cippitelli A; Nava F; Piomelli D; Rodríguez de Fonseca F
    J Neurosci; 2002 Nov; 22(21):9612-7. PubMed ID: 12417686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats.
    Serrano A; Del Arco I; Javier Pavón F; Macías M; Perez-Valero V; Rodríguez de Fonseca F
    Neuropharmacology; 2008 Jan; 54(1):226-34. PubMed ID: 17467748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute anorectic response to cannabinoid CB1 receptor antagonist/inverse agonist AM 251 in rats: indirect behavioural mediation.
    Tallett AJ; Blundell JE; Rodgers JR
    Behav Pharmacol; 2007 Nov; 18(7):591-600. PubMed ID: 17912043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grooming, scratching and feeding: role of response competition in acute anorectic response to rimonabant in male rats.
    Tallett AJ; Blundell JE; Rodgers RJ
    Psychopharmacology (Berl); 2007 Nov; 195(1):27-39. PubMed ID: 17639351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of endocannabinoids and their analogues in obesity and eating disorders.
    Gaetani S; Kaye WH; Cuomo V; Piomelli D
    Eat Weight Disord; 2008 Sep; 13(3):e42-8. PubMed ID: 19011363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential modulation of plasma ghrelin and glucagon-like peptide-1 by anorexigenic cannabinoid compounds, SR141716A (rimonabant) and oleoylethanolamide.
    Cani PD; Montoya ML; Neyrinck AM; Delzenne NM; Lambert DM
    Br J Nutr; 2004 Nov; 92(5):757-61. PubMed ID: 15533263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cannabinoid CB1 receptor inverse agonist AM 251 and antagonist AM 4113 produce similar effects on the behavioral satiety sequence in rats.
    Hodge J; Bow JP; Plyler KS; Vemuri VK; Wisniecki A; Salamone JD; Makriyannis A; McLaughlin PJ
    Behav Brain Res; 2008 Nov; 193(2):298-305. PubMed ID: 18602425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oleoylethanolamide inhibits food intake in free-feeding rats after oral administration.
    Oveisi F; Gaetani S; Eng KT; Piomelli D
    Pharmacol Res; 2004 May; 49(5):461-6. PubMed ID: 14998556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociable effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in the novelty-induced hypophagia test in mice.
    Gamble-George JC; Conger JR; Hartley ND; Gupta P; Sumislawski JJ; Patel S
    Psychopharmacology (Berl); 2013 Aug; 228(3):401-9. PubMed ID: 23483200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats.
    Scherma M; Fattore L; Satta V; Businco F; Pigliacampo B; Goldberg SR; Dessi C; Fratta W; Fadda P
    Br J Pharmacol; 2013 Jun; 169(4):820-33. PubMed ID: 23072421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment with subeffective doses of Rimonabant attenuates orexigenic actions of orexin A-hypocretin 1.
    Crespo I; Gómez de Heras R; Rodríguez de Fonseca F; Navarro M
    Neuropharmacology; 2008 Jan; 54(1):219-25. PubMed ID: 17889909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central versus peripheral antagonism of cannabinoid CB1 receptor in obesity: effects of LH-21, a peripherally acting neutral cannabinoid receptor antagonist, in Zucker rats.
    Pavón FJ; Serrano A; Pérez-Valero V; Jagerovic N; Hernández-Folgado L; Bermúdez-Silva FJ; Macías M; Goya P; de Fonseca FR
    J Neuroendocrinol; 2008 May; 20 Suppl 1():116-23. PubMed ID: 18426510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dose naloxone attenuates the pruritic but not anorectic response to rimonabant in male rats.
    Wright FL; Rodgers RJ
    Psychopharmacology (Berl); 2013 Mar; 226(2):415-31. PubMed ID: 23142959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrasting effects of different cannabinoid receptor ligands on mouse ingestive behaviour.
    Grey J; Terry P; Higgs S
    Behav Pharmacol; 2012 Sep; 23(5-6):551-9. PubMed ID: 22772336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of the anorexic compound oleoylethanolamide on gastric emptying in control and overweight mice.
    Aviello G; Matias I; Capasso R; Petrosino S; Borrelli F; Orlando P; Romano B; Capasso F; Di Marzo V; Izzo AA
    J Mol Med (Berl); 2008 Apr; 86(4):413-22. PubMed ID: 18278475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous opioids and cannabinoids: system interactions in the regulation of appetite, grooming and scratching.
    Tallett AJ; Blundell JE; Rodgers RJ
    Physiol Behav; 2008 Jun; 94(3):422-31. PubMed ID: 18394662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cannabinoid receptor antagonist SR 141716 attenuates overfeeding induced by systemic or intracranial morphine.
    Verty AN; Singh ME; McGregor IS; Mallet PE
    Psychopharmacology (Berl); 2003 Jul; 168(3):314-23. PubMed ID: 12700881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rimonabant precipitates anxiety in rats withdrawn from palatable food: role of the central amygdala.
    Blasio A; Iemolo A; Sabino V; Petrosino S; Steardo L; Rice KC; Orlando P; Iannotti FA; Di Marzo V; Zorrilla EP; Cottone P
    Neuropsychopharmacology; 2013 Nov; 38(12):2498-507. PubMed ID: 23793355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.